FTC sues top PBMs for inflating insulin prices, accusing them of rigging competition and hurting patients. Legal action also includes GPOs.
FTC's action today is likely only the tip of the iceberg of necessary reforms to end PBMs' harmful business practices that have directly led to the lights going out for thousands of independent ...
The Federal Trade Commission has accused three major pharmacy benefit managers of inflating insulin prices, the agency said ...
The federal government is suing some pharmacy benefit managers over a system of drug rebates that regulators say has made the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback